Hi there!
We track 52,000+ AI startups and surface hidden job opportunities that never appear on LinkedIn. Tell us what you're looking for, our AI agent does the searching. It's free and you sign up using Google. Go explore!
Pear Bio
Pear Bio is a biotech company focused on patient-centered cancer precision medicine, delivering functional precision medicine tests and therapeutics for hard-to-treat cancers. They create…
Pear Bio
Pear Bio is a biotech company focused on patient-centered cancer precision medicine, delivering functional precision medicine tests and therapeutics for hard-to-treat cancers. They create…
TL;DR
Focus: Functional precision medicine for hard-to-treat cancers using patient-derived 3D immune-microtumors
Headquarters / Sites: Operations in Natick, MA (U.S.) and a Translation & Innovation Hub in London
Founded: 2017 (company materials) / 2019 referenced in some profiles
Recent financing: Series A announced Aug 22, 2023
Company Overview
Problem Domain
Precision oncology; predicting patient response to therapies and discovering new cancer therapeutics.
Founded
2017
Industry
Biotechnology
Tech Stack
Funding Track Record
Series A announced Aug 22, 2023 (profiles also reference a Series A announced May 15, 2023 in some sources)
Investor Signal
“Compound, Crista Galli Ventures, Fly Ventures, Greater London Authority, Hoxton Ventures, Octopus Ventures, RebelBio, SOSV, SoftBank Vision Fund Emerge Program, Wavemaker 360”